244 related articles for article (PubMed ID: 32542308)
1. Artesunate inhibits osteoclastogenesis through the miR-503/RANK axis.
Huang MZ; Zhuang Y; Ning X; Zhang H; Shen ZM; Shang XW
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32542308
[TBL] [Abstract][Full Text] [Related]
2. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
3. Oleanolic acid inhibits RANKL-induced osteoclastogenesis via ER alpha/miR-503/RANK signaling pathway in RAW264.7 cells.
Xie BP; Shi LY; Li JP; Zeng Y; Liu W; Tang SY; Jia LJ; Zhang J; Gan GX
Biomed Pharmacother; 2019 Sep; 117():109045. PubMed ID: 31176167
[TBL] [Abstract][Full Text] [Related]
4. MiR-143 Inhibits Osteoclastogenesis by Targeting RANK and NF-κB and MAPK Signaling Pathways.
He X; Zhu L; An L; Zhang J
Curr Mol Pharmacol; 2020; 13(3):224-232. PubMed ID: 31951177
[TBL] [Abstract][Full Text] [Related]
5. Ellagic acid blocks RANKL-RANK interaction and suppresses RANKL-induced osteoclastogenesis by inhibiting RANK signaling pathways.
Xu H; Chen F; Liu T; Xu J; Li J; Jiang L; Wang X; Sheng J
Chem Biol Interact; 2020 Nov; 331():109235. PubMed ID: 32971123
[TBL] [Abstract][Full Text] [Related]
6. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
7. Oxidation derivative of (-)-epigallocatechin-3-gallate (EGCG) inhibits RANKL-induced osteoclastogenesis by suppressing RANK signaling pathways in RAW 264.7 cells.
Xu H; Liu T; Li J; Xu J; Chen F; Hu L; Zhang B; Zi C; Wang X; Sheng J
Biomed Pharmacother; 2019 Oct; 118():109237. PubMed ID: 31376653
[TBL] [Abstract][Full Text] [Related]
8. A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NFκB and MAPK signaling in RAW264.7 cells.
Nikhil K; Sharan S; Roy P
Pharmacol Rep; 2015 Dec; 67(6):1264-72. PubMed ID: 26481551
[TBL] [Abstract][Full Text] [Related]
9. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
Chen X; Zhi X; Pan P; Cui J; Cao L; Weng W; Zhou Q; Wang L; Zhai X; Zhao Q; Hu H; Huang B; Su J
FASEB J; 2017 Nov; 31(11):4855-4865. PubMed ID: 28739641
[TBL] [Abstract][Full Text] [Related]
10. Dencichine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis by inhibiting RANKL-associated NF-κB and MAPK signaling pathways.
Cang D; Zou G; Yang C; Shen X; Li F; Wu Y; Ji B
J Pharmacol Sci; 2021 Aug; 146(4):206-215. PubMed ID: 34116734
[TBL] [Abstract][Full Text] [Related]
11. Diaporisoindole E inhibits RANKL-induced osteoclastogenesis via suppression of PI3K/AKT and MAPK signal pathways.
Hua P; Cui H; Xu J; Cai R; She Z; Gu Q
Phytomedicine; 2020 Aug; 75():153234. PubMed ID: 32510335
[TBL] [Abstract][Full Text] [Related]
12. Zanthoxylum bungeanum seed oil inhibits RANKL-induced osteoclastogenesis by suppressing ERK/c-JUN/NFATc1 pathway and regulating cell cycle arrest in RAW264.7 cells.
He F; Luo S; Liu S; Wan S; Li J; Chen J; Zuo H; Pei X
J Ethnopharmacol; 2022 May; 289():115094. PubMed ID: 35149133
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing NF-κB and MAPK signaling pathways.
Xu H; Liu T; Jia Y; Li J; Jiang L; Hu C; Wang X; Sheng J
Int Immunopharmacol; 2021 Jun; 95():107464. PubMed ID: 33677256
[TBL] [Abstract][Full Text] [Related]
14. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
15. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
[TBL] [Abstract][Full Text] [Related]
16. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
17. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
Chang CC; Tsai YH; Liu Y; Lin SY; Liang YC
Rheumatology (Oxford); 2015 Oct; 54(10):1913-22. PubMed ID: 25998451
[TBL] [Abstract][Full Text] [Related]
18. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
[TBL] [Abstract][Full Text] [Related]
19. Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro.
Kim EY; Kim JH; Kim M; Park JH; Sohn Y; Jung HS
J Ethnopharmacol; 2020 Jul; 257():112828. PubMed ID: 32268206
[TBL] [Abstract][Full Text] [Related]
20. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
